Insiders Updates Oruka Therapeutics Inc (ORKA) rating initates by BTIG Research Oruka Therapeutics Inc’s filing revealed that its 10% Owner Venrock Healthcare Capital Par acquired Company’s shares for reported $1.02 million
Analysts Viewpoint Analyzing Oruka Therapeutics Inc (ORKA) After Recent Trading Activity Oruka Therapeutics Inc’s recent filing unveils that its 10% Owner Venrock Healthcare Capital Par acquired Company’s shares for reported $1.02